云南水务(06839.HK)售内地联营公司股权 获发21亿人币代价股份支付
云南水务(06839.HK)公布,钱江生化(600796.SH)拟收购包括云南水务持股的4家公司的股权,总代价为21.03亿元人民币(下同)。於收购事项完成後,钱江生化将持有浙江海云环保100%股权、首创水务40%股权、实康水务40%股权及绿动海云40%股权。
钱江生化将透过发行代价股份结算,每股代价股份约4.43元,代价股份总数为4.75亿股,占其扩大後股权约61.2%。
於交易事项完成後,云南水务将不再持有浙江海云环保任何股权,并将持有钱江生化约22.6%股权,而钱江生化将作为公司的联营公司入账。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.